Articles with public access mandates - Youssef DaaliLearn more
Not available anywhere: 8
Analgesics in patients with hepatic impairment: pharmacology and clinical implications
M Bosilkovska, B Walder, M Besson, Y Daali, J Desmeules
Drugs 72, 1645-1669, 2012
Mandates: Swiss National Science Foundation
Why has model‐informed precision dosing not yet become common clinical reality? Lessons from the past and a roadmap for the future
AS Darwich, K Ogungbenro, AA Vinks, JR Powell, JL Reny, N Marsousi, ...
Clinical Pharmacology & Therapeutics 101 (5), 646-656, 2017
Mandates: UK Medical Research Council
Intestinal permeability and P‐glycoprotein‐mediated efflux transport of ticagrelor in Caco‐2 monolayer cells
N Marsousi, F Doffey‐Lazeyras, S Rudaz, JA Desmeules, Y Daali
Fundamental & clinical pharmacology 30 (6), 577-584, 2016
Mandates: Swiss National Science Foundation
Aspirin response: Differences in serum thromboxane B2 levels between clinical studies
C Brun, Y Daali, C Combescure, A Zufferey, AD Michelson, P Fontana, ...
Platelets 27 (3), 196-202, 2016
Mandates: Swiss National Science Foundation
Pharmacogenomics of oral antithrombotic drugs
F Storelli, Y Daali, J Desmeules, JL Reny, P Fontana
Current pharmaceutical design 22 (13), 1933-1949, 2016
Mandates: Swiss National Science Foundation
GABAergic modulation of secondary hyperalgesia: a randomized controlled 4‐way crossover trial with the α2‐subunit preferring GABA positive allosteric modulator, N‐desmethyl …
A Matthey, Y Daali, F Curtin, A Poncet, J Desmeules, M Besson
European Journal of Pain 24 (6), 1094-1106, 2020
Mandates: Swiss National Science Foundation
Evidence-based choice of P2Y12 inhibitors in end stage renal disease patients: a mini-review
Y Bouatou, C Flora Samer, P Fontana, Y Daali, J Desmeules
Current drug metabolism 16 (2), 97-104, 2015
Mandates: Swiss National Science Foundation
Liquid chromatography-tandem mass spectrometry method for ticagrelor and its active metabolite determination in human plasma: Application to a pharmacokinetic study
N Marsousi, S Rudaz, JA Desmeules, Y Daali
Current Analytical Chemistry 16 (5), 602-608, 2020
Mandates: Swiss National Science Foundation
Available somewhere: 38
The AmpliChip CYP450 test: cytochrome P450 2D6 genotype assessment and phenotype prediction
MC Rebsamen, J Desmeules, Y Daali, A Chiappe, A Diemand, C Rey, ...
The pharmacogenomics journal 9 (1), 34-41, 2009
Mandates: Swiss National Science Foundation
NADPH oxidase NOX2 defines a new antagonistic role for reactive oxygen species and cAMP/PKA in the regulation of insulin secretion
N Li, B Li, T Brun, C Deffert-Delbouille, Z Mahiout, Y Daali, XJ Ma, ...
Diabetes 61 (11), 2842-2850, 2012
Mandates: Swiss National Science Foundation
Mesoporous silica nanoparticles as pH-responsive carrier for the immune-activating drug resiquimod enhance the local immune response in mice
J Wagner, D Gößl, N Ustyanovska, M Xiong, D Hauser, O Zhuzhgova, ...
ACS nano 15 (3), 4450-4466, 2021
Mandates: Swiss National Science Foundation, German Research Foundation
HZ166, a novel GABAA receptor subtype-selective benzodiazepine site ligand, is antihyperalgesic in mouse models of inflammatory and neuropathic pain
A Di Lio, D Benke, M Besson, J Desmeules, Y Daali, Z Wang, R Edwankar, ...
Neuropharmacology 60 (4), 626-632, 2011
Mandates: Swiss National Science Foundation
Impact of boosted antiretroviral therapy on the pharmacokinetics and efficacy of clopidogrel and prasugrel active metabolites
N Marsousi, Y Daali, P Fontana, JL Reny, V Ancrenaz-Sirot, A Calmy, ...
Clinical pharmacokinetics 57, 1347-1354, 2018
Mandates: Swiss National Science Foundation, National Fund for Scientific Research …
Real‐time monitoring of exhaled drugs by mass spectrometry
C Berchtold, M Bosilkovska, Y Daali, B Walder, R Zenobi
Mass spectrometry reviews 33 (5), 394-413, 2014
Mandates: Swiss National Science Foundation
Influence of the paraoxonase‐1 Q192R genetic variant on clopidogrel responsiveness and recurrent cardiovascular events: a systematic review and meta‐analysis
JL Reny, C Combescure, Y Daali, P Fontana
Journal of Thrombosis and Haemostasis 10 (7), 1242-1251, 2012
Mandates: US National Institutes of Health
Evaluation of NADPH oxidases as drug targets in a mouse model of familial amyotrophic lateral sclerosis
T Seredenina, Z Nayernia, S Sorce, GJ Maghzal, A Filippova, SC Ling, ...
Free Radical Biology and Medicine 97, 95-108, 2016
Mandates: National Health and Medical Research Council, Australia
Molecular imaging reveals rapid reduction of endothelial activation in early atherosclerosis with apocynin independent of antioxidative properties
E Khanicheh, Y Qi, A Xie, M Mitterhuber, L Xu, M Mochizuki, Y Daali, ...
Arteriosclerosis, thrombosis, and vascular biology 33 (9), 2187-2192, 2013
Mandates: Swiss National Science Foundation, US National Institutes of Health
GABAergic modulation in central sensitization in humans: a randomized placebo-controlled pharmacokinetic–pharmacodynamic study comparing clobazam with clonazepam in healthy …
M Besson, A Matthey, Y Daali, A Poncet, P Vuillemier, M Curatolo, ...
Pain 156 (3), 397-404, 2015
Mandates: Swiss National Science Foundation
Coadministration of ticagrelor and ritonavir: toward prospective dose adjustment to maintain an optimal platelet inhibition using the PBPK approach
N Marsousi, CF Samer, P Fontana, JL Reny, S Rudaz, JA Desmeules, ...
Clinical Pharmacology & Therapeutics 100 (3), 295-304, 2016
Mandates: Swiss National Science Foundation
Development and validation of a chemical hydrolysis method for dextromethorphan and dextrophan determination in urine samples: application to the assessment of CYP2D6 activity …
Y Daali, S Cherkaoui, F Doffey-Lazeyras, P Dayer, JA Desmeules
Journal of Chromatography B 861 (1), 56-63, 2008
Mandates: Swiss National Science Foundation
Publication and funding information is determined automatically by a computer program